Cancer becomes metastatic when it has started to spread to other parts of the body, outside of the originally affected area. Metastatic bladder cancer medicine is available for the treatment of bladder cancer. Below are some of five of the many types of drugs used in medicines and therapies to help treat bladder cancer.
Metastatic Bladder Cancer Medicine
Avelumab is a drug that can treat metastatic bladder cancer in patients who have had their cancer worsen during or after platinum chemotherapy. It is also known as Bavencio and has been approved by the US Food and Drug Administration (FDA).
Cisplatin is an FDA-approved drug that can help with the treatment of bladder cancer that is not treatable by radiation therapy or surgery.
Durvalumab is a drug similar to Avelumab and can be used to treat bladder cancer that has metastasized and became worse during or after platinum chemotherapy. This drug is also known as Imfinzi and is FDA-approved as well.
Nivolumab is also used to treat people with bladder cancer that has metastasized or gotten worse due to platinum chemotherapy. It is FDA-approved and can also be known as Opdivo.
Pembrolizumab is a drug that can be used for patients who are unable to be treated with Cisplatin. It can also treat those with worsened conditions during or after having platinum chemotherapy. Pembrolizumab is FDA-approved and is also known as Keytruda.
Not all drugs meant for the treatment of bladder cancer are suitable for metastatic bladder cancer. Remember to talk to a doctor or oncologist to determine which treatment could work best for you and your case of metastatic bladder cancer.
Be sure to discuss all possible side effects that may occur due to the treatment you choose with your doctor or an oncologist.
Featured Image: DepositPhotos/j.dudzinski